Vestal Point Capital’s Olema Oncology OLMA Stock Holding History
Bought
Maintained
Sold
Other funds holding OLMA
SL
Vestal Point Capital's OLMA Position: Q3 2026 in Review
Vestal Point Capital increased its Olema Oncology (OLMA) stake by 0.35% in Q3 2026, buying an estimated $15.8K and bringing the position to 420,000 shares worth $3.63M. The position accounts for 0.09% of the portfolio, ranked #53.
Vestal Point Capital first reported a position in OLMA in Q4 2025 and has held it in 4 quarters since. The position peaked at $41.2M in Q4 2025. 179 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.
- Vestal Point Capital held 420,000 shares of Olema Oncology worth $3.63M as of Q3 2026.
- Vestal Point Capital bought 1,449 Olema Oncology shares in Q3 2026, an estimated $15.8K.
- Olema Oncology made up 0.09% of Vestal Point Capital's portfolio in Q3 2026, its #53 holding.
- Vestal Point Capital first reported a position in Olema Oncology in Q4 2025 and has held it in 4 quarters since.
- Vestal Point Capital's Olema Oncology position peaked at $41.2M in Q4 2025.
- 179 funds tracked by Wall St. Rank held Olema Oncology as of Q3 2026.
Based on Vestal Point Capital's 13F filing for Q3 2026, filed 16 Nov 2026.